Literature DB >> 92181

Virus augmentation of the antigenicity of tumor cell extracts.

F C Austin, C W Boone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 92181     DOI： 10.1016/s0065-230x(08)60900-8

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN： 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  18 in total

1.  Dendritic cells loaded with the lysate of tumor cells infected with Newcastle Disease Virus trigger potent anti-tumor immunity by promoting the secretion of IFN-γ and IL-2 from T cells.

Authors:  Lianjing Zhao; Chao Niu; Xiumin Shi; Dongsheng Xu; Min Li; Jiuwei Cui; Wei Li; Jianting Xu; Haofan Jin
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

Review 2.  Whole tumor antigen vaccines.

Authors:  Cheryl Lai-Lai Chiang; Fabian Benencia; George Coukos
Journal:  Semin Immunol       Date:  2010-03-30       Impact factor: 11.130

3.  Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation.

Authors:  H Schild; P von Hoegen; V Schirrmacher
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Immunotherapy of the rat 13762SC mammary adenocarcinoma by vaccinia virus augmentation of tumor immunity.

Authors:  T P Archer; P Bretscher; B Ziola
Journal:  Clin Exp Metastasis       Date:  1990 Nov-Dec       Impact factor: 5.150

5.  Antigenic variation in cancer metastasis: immune escape versus immune control.

Authors:  V Schirrmacher; M Fogel; E Russmann; K Bosslet; P Altevogt; L Beck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

6.  Characteristics of reovirus-mediated chemoimmunotherapy of murine L1210 leukemia.

Authors:  J S Bryson; D C Cox
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  Virus-augmented delayed hypersensitivity skin tests in gynecological malignancies.

Authors:  R S Freedman; J M Bowen; E N Atkinson; W Scott; S Wagner
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

8.  Susceptibility of Marek's disease lymphoblastoid cell lines to infection with influenza and pseudorabies viruses and the protective effect of immunization with influenza virus-infected lymphoblastoid cells.

Authors:  L J Ross; J M Bumstead; P C Powell
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

9.  Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates.

Authors:  P Hersey; A Edwards; A Coates; H Shaw; W McCarthy; G Milton
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

10.  Immune responses of DBA/2 mice bearing melanoma tumors: cell-mediated immune responses after challenge with vaccinia virus.

Authors:  J A Byrne; M Soloski; J A Holowczak
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.